Pathological ventricular remodeling: mechanisms: part 1 of 2

JS Burchfield, M **e, JA Hill - Circulation, 2013 - ahajournals.org
Despite declines in heart failure morbidity and mortality with current therapies,
rehospitalization rates remain distressingly high, substantially affecting individuals, society …

Cardiopulmonary bypass-induced inflammatory response: pathophysiology and treatment

RA Bronicki, M Hall - Pediatric Critical Care Medicine, 2016 - journals.lww.com
Objectives: The objectives of this review are to discuss the pathophysiology of the pro-
inflammatory response to the cardiopulmonary bypass circuit, the impact of ischemia …

What is the role of the inflammation in the pathogenesis of heart failure?

EC Castillo, E Vázquez-Garza, D Yee-Trejo… - Current Cardiology …, 2020 - Springer
Abstract Purpose of Review In heart failure, whether it is associated with reduced or
preserved ejection fraction, the immune system is activated and contributes to heart …

The role of B cells in heart failure and implications for future immunomodulatory treatment strategies

G García‐Rivas, EC Castillo… - ESC Heart …, 2020 - Wiley Online Library
Despite numerous demonstrations that the immune system is activated in heart failure,
negatively affecting patients' outcomes, no definitive treatment strategy exists directed to …

Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases

EG Rosenbaugh, KK Savalia… - American Journal …, 2013 - journals.physiology.org
Cardiovascular diseases, including hypertension and heart failure, are associated with
activation of the renin-angiotensin system (RAS) and increased circulating and tissue levels …

Role of adaptive immunity in the development and progression of heart failure: new evidence

L Sánchez-Trujillo, E Vázquez-Garza… - Archives of Medical …, 2017 - Elsevier
Heart failure (HF) is considered the endpoint of a variety of cardiac diseases, which are the
leading cause of death in adults and considered a growing pandemic worldwide …

Identification MNS1, FRZB, OGN, LUM, SERP1NA3 and FCN3 as the potential immune-related key genes involved in ischaemic cardiomyopathy by random forest and …

PF Zheng, F Liu, ZF Zheng, HW Pan… - Aging (Albany NY …, 2023 - pmc.ncbi.nlm.nih.gov
The immune molecular mechanisms involved in ischaemic cardiomyopathy (ICM) have not
been fully elucidated. The current study aimed to elucidate the immune cell infiltration …

The physiology of cardiovascular disease and innovative liposomal platforms for therapy

GU Ruiz-Esparza, JH Flores-Arredondo… - International journal …, 2013 - Taylor & Francis
Heart disease remains the major cause of death in males and females, emphasizing the
need for novel strategies to improve patient treatment and survival. A therapeutic approach …

Unresolved issues in left ventricular postischemic remodeling and progression to heart failure

E Gronda, S Sacchi, G Benincasa… - Journal of …, 2019 - journals.lww.com
In the past decades, myocardial infarction periacute mortality markedly declined since
coronary reperfusion therapy has been adopted. Despite immediate benefits of coronary …

Mechanisms and consequences of inflammatory signaling in the myocardium

J Ahn, J Kim - Current hypertension reports, 2012 - Springer
To further understand chronic heart disease, such as heart failure and cardiomyopathy, we
must fully define signaling pathways within the myocardium. Recent studies suggest that …